← Back to Search

Cranial non-contrast syngo DynaCT Sine Spin scan for Stroke (SPINNERS Trial)

Led By Marios-Nikos Psychogios, Prof Dr
Research Sponsored by University Hospital, Basel, Switzerland
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient presenting within 24 hours of last seen well
Age above 18 years
Screening 3 weeks
Treatment Varies
Follow Up day 0 - within 4 hours of enrollment
Awards & highlights

SPINNERS Trial Summary

This trial aims to determine if a specific type of imaging, called non-contrast syngo DynaCT Sine Spin, is as effective as another type of imaging, called non-contrast MDCT

Who is the study for?
This trial is for adults over 18 with symptoms of a stroke, who can give informed consent and arrive at the hospital within 24 hours of their last known well time. They should be able to have two types of head scans within four hours. It's not suitable for those who don't meet these timing or consent requirements.Check my eligibility
What is being tested?
The study tests if a new type of non-contrast head scan called syngo DynaCT Sine Spin is as good as the standard non-contrast MDCT scan in detecting bleeding inside the skull after a stroke.See study design
What are the potential side effects?
Since both interventions are diagnostic imaging techniques rather than medications, they do not have typical side effects like drugs do. However, there may be risks associated with exposure to radiation.

SPINNERS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I sought medical help within 24 hours of feeling unwell.
I am older than 18 years.
I have had a stroke with significant symptoms and received specific scans within 4 hours.

SPINNERS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 - within 4 hours of enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 - within 4 hours of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Occurrence of an intracranial hemorrhage (yes/no)
Other outcome measures
Change in Adverse Device Events (ADEs)

SPINNERS Trial Design

1Treatment groups
Experimental Treatment
Group I: Cranial non-contrast syngo DynaCT Sine Spin scanExperimental Treatment2 Interventions
There is only one arm as all patients undergo the same intervention. Subjects with clinical features/symptoms of a stroke (hemorrhagic and non-hemorrhagic stroke patients) will be enrolled. All patients will undergo first a non-contrast MDCT scan and then a non-contrast syngo DynaCT Sine Spin head scan within a maximum timespan of 4 hours between both scans. Only patients in which no invasive procedure in between is planned can be enrolled.

Find a Location

Who is running the clinical trial?

University Hospital, Basel, SwitzerlandLead Sponsor
963 Previous Clinical Trials
1,853,554 Total Patients Enrolled
16 Trials studying Stroke
9,296 Patients Enrolled for Stroke
Siemens Healthineers AGUNKNOWN
2 Previous Clinical Trials
2,278 Total Patients Enrolled
1 Trials studying Stroke
50 Patients Enrolled for Stroke
Adam S Arthur, MD, MPHStudy ChairSemmes Murphey Clinic and University of Tennessee Health Sciences Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals being enrolled in this clinical trial?

"Indeed, the details provided on clinicaltrials.gov indicate that this particular clinical trial is presently in the recruitment phase. The initial posting of the trial occurred on October 25th, 2022, with the most recent update made on January 23rd, 2024. A total of four medical sites are enrolling a targeted number of 252 participants for this study."

Answered by AI

In how many distinct locations is this investigation currently being conducted?

"In addition to University Hospital Basel in Basel, Inselspital Bern in Bern, and Kantonsspital Luzern in Luzern, there are four other locations where this study is being conducted."

Answered by AI

Is the enrollment for this study currently available to prospective participants?

"Indeed, the information obtained from clinicaltrials.gov confirms that this study is actively seeking eligible participants. The trial was initially posted on October 25th, 2022 and recently updated on January 23rd, 2024. A total of four sites are enrolling a targeted number of 252 individuals for participation in this research endeavor."

Answered by AI
~0 spots leftby May 2024